Cerebrospinal Fluid Neuron-Specific Enolase Following Seizures in Children: Role of Etiology

Abstract

Neuron-specific enolase, a marker for neuronal injury, is elevated following seizures in adults, but relatively few data exist on postictal neuron-specific enolase levels in children. This study measured cerebrospinal fluid (CSF) neuron-specific enolase levels after seizures in 49 consecutive pediatric patients and investigated the role of seizure type, duration, and etiology in influencing neuron-specific enolase. Overall, there was no significant difference in neuron-specific enolase levels between patients with seizures and a control group. However, 4 of the 49 seizure patients (8%) had neuron-specific enolase levels clearly above the normal range. Seizure patients with symptomatic etiologies had significantly increased neuron-specific enolase compared to cryptogenic/idiopathic or febrile seizures. The four individual patients with elevated cerebrospinal fluid neuron-specific enolase all had identified metabolic or genetic etiologies and presented with medically refractory status epilepticus. No individuals with cryptogenic/idiopathic or febrile seizures had abnormal neuron-specific enolase. There was no significant effect of seizure duration or type on cerebrospinal fluid neuron-specific enolase. In contrast to adults, acute seizure-induced neuronal injury in children as detected by neuron-specific enolase is rare and may occur primarily with severe symptomatic etiologies. Children with cryptogenic, idiopathic, or febrile seizures, including status epilepticus, are at relatively low risk for neuronal damage following seizures. (J Child Neurol 2002;17:261-264).

Get full access to this article

View all access options for this article.

References

Norman RM : The neuropathology of status epilepticus. Med Sci Law 1964;4:46-51.

Tasch E. , Cendes F. , Li LM , et al: Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy. Ann Neurol 1999 ;45:568-576.

Fuerst D. , Shah J. , Kupsky WJ , et al: Volumetric MRI, pathological, and neuropsychological progression in hippocampal sclerosis. Neurology 2001;57:184-188.

Meldrum BS , Vigouroux RA , Brierley JB : Systemic factors and epileptic brain damage. Arch Neurol 1973;29:82-87.

Nitecka L. , Tremblay E. , Charton G. , et al: Maturation of kainic acid seizure-brain damage syndrome in the rat. II. Histopathological sequelae. Neuroscience 1984;13:1073-1094.

Persson L. , Hardemark HG , Gustafsson J. , et al: S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: Markers of cell damage in human central nervous system. Stroke 1987; 18:911-918.

Missler U. , Wiesmann M. , Friedrich C. , Kaps M. : S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke . Stroke 1997;28:1956-1960.

DeGiorgio CM , Correale JD , Gott PS , et al: Serum neuron-specific enolase in human status epilepticus. Neurology 1995;45:1134-1137.

Correale JD , Rabinowicz AL , Heck CN , et al: Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier. Neurology 1998;50:1388-1391.

10.

DeGiorgio CM , Heck CN , Rabinowicz AL , et al: Serum neuron-specific enolase in the major subtypes of status epilepticus. Neurology 1999;52:746-749.

11.

Rabinowicz AL , Correale J. , Boutros RB , et al: Neuron-specific enolase is increased after single seizures during inpatient video/EEG monitoring . Epilepsia 1996;37:122-125.

12.

Tumani H. , Otto M. , Gefeller O. , et al: Kinetics of serum neuron-specific enolase and prolactin in patients after single epileptic seizures. Epilepsia 1999;40:713-718.

13.

Buttner T. , Lack B. , Jager M. , et al: Serum levels of neuron-specific enolase and S-100 protein after single tonic-clonic seizures. J Neurol 1999 ;246:459-461.

14.

Rodriguez-Nunez A. , Cid E. , Rodriguez-Garcia J. , et al: Cerebrospinal fluid purine metabolite and neuron-specific enolase concentrations after febrile seizures. Brain Dev 2000;22:427-431.

15.

Tanabe T. , Suzuki S. , Hara K. , et al: Cerebrospinal fluid and serum neuron-specific enolase levels after febrile seizures. Epilepsia 2001; 42:504-507.

16.

Suzuki Y. , Toribe Y. , Goto M. , et al: Serum and CSF neuron-specific enolase in patients with West syndrome. Neurology 1999;53: 1761-1764.

17.

Wong M. , Schlaggar BL , Buller RS , et al: Cerebrospinal fluid protein concentration in pediatric patients: Defining clinically relevant reference values. Arch Pediatr Adolesc Med 2000;154:827-831.

18.

Wong M. , Schlaggar BL , Landt M. : Postictal cerebrospinal fluid abnormalities in children. J Pediatr 2001;138:373-377.

19.

van Engelen BG , Lamers KJ , Gabreels FJ , et al: Age-related changes of neuron-specific enolase, S-100 protein, and myelin basic protein concentrations in cerebrospinal fluid. Clin Chem 1992;38:813-816.

20.

O'Regan ME , Brown JK : Serum neuron specific enolase: A marker for neuronal dysfunction in children with continuous EEG epileptiform activity. Eur J Paediatr Neurol 1998;2:193-197.

21.

Ko FJ , Chiang CH , Wu CC , Wu L. : Studies of neuron-specific enolase levels in serum and cerebrospinal fluid of children with neurological diseases. Kaohsiung J Med Sci 1990;6:137-143.